Krystal Biotech, Inc. (KRYS)
336.90
-1.85
(-0.55%)
USD |
NASDAQ |
Sep 18, 16:00
336.90
0.00 (0.00%)
After-Hours: 20:00
Krystal Biotech Cash from Operations (Quarterly) : 74.79M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 74.79M |
| March 31, 2026 | 80.38M |
| December 31, 2025 | 77.51M |
| September 30, 2025 | 39.66M |
| June 30, 2025 | 52.73M |
| March 31, 2025 | 30.97M |
| December 31, 2024 | 52.84M |
| September 30, 2024 | 58.86M |
| June 30, 2024 | -4.168M |
| March 31, 2024 | 15.89M |
| December 31, 2023 | -7.232M |
| September 30, 2023 | -21.23M |
| June 30, 2023 | -34.19M |
| March 31, 2023 | -26.16M |
| December 31, 2022 | -22.33M |
| September 30, 2022 | -19.69M |
| June 30, 2022 | -43.06M |
| March 31, 2022 | -15.49M |
| December 31, 2021 | -20.90M |
| September 30, 2021 | -7.255M |
| June 30, 2021 | -10.13M |
| Date | Value |
|---|---|
| March 31, 2021 | -9.654M |
| December 31, 2020 | -8.024M |
| September 30, 2020 | -6.766M |
| June 30, 2020 | -5.066M |
| March 31, 2020 | -6.227M |
| December 31, 2019 | -7.046M |
| September 30, 2019 | -4.243M |
| June 30, 2019 | -4.209M |
| March 31, 2019 | -3.215M |
| December 31, 2018 | -3.518M |
| September 30, 2018 | -1.94M |
| June 30, 2018 | -1.618M |
| March 31, 2018 | -2.369M |
| December 31, 2017 | -2.127M |
| September 30, 2017 | -1.098M |
| June 30, 2017 | -0.408M |
| March 31, 2017 | -0.257M |
| December 31, 2016 | -0.861M |
| September 30, 2016 | -0.311M |
| June 30, 2016 | -0.139M |
| March 31, 2016 | 0.00 |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| TG Therapeutics, Inc. | 39.26M |
| Cytokinetics, Inc. | -159.84M |
| Alnylam Pharmaceuticals, Inc. | 326.72M |
| Exelixis, Inc. | 307.74M |
| Regeneron Pharmaceuticals, Inc. | 813.00M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -161.58M |
| Cash from Financing (Quarterly) | 15.05M |
| Free Cash Flow | 257.78M |
| Free Cash Flow Per Share (Quarterly) | 2.323 |
| Free Cash Flow to Equity (Quarterly) | 71.48M |
| Free Cash Flow to Firm (Quarterly) | 71.22M |
| Free Cash Flow Yield | 2.52% |